CJC-1295 (No DAC) - available in 2mg, 5mg, 10mg. For laboratory research use only. Not for human or veterinary use.
CJC-1295 (no DAC), also called Modified GRF (1-29), is a synthetic 29-amino acid peptide and modified analog of growth hormone-releasing hormone (GHRH). First synthesized in the early 2000s, it replicates the first 29 amino acids of native GHRH with four strategic substitutions at positions 2, 8, 15, and 27 that resist cleavage by dipeptidyl peptidase-IV (DPP-IV). The “no DAC” label means this version lacks the Drug Affinity Complex used in the longer-acting variant. Molecular formula: C152H252N44O42; weight: approximately 3,368 g/mol; CAS: 446036-97-1. Supplied as a lyophilized powder, soluble in water.
This product is strictly for research purposes only.
Product Finder
Two quick questions route you to the compound most aligned with your research focus, plus what's commonly studied alongside it.
For research routing only, not a medical assessment. All compounds are sold for laboratory research use only.
Question 1 of 2
Pick the pathway closest to your current work, you can browse the rest anytime.
Question 2 of 2
Helps us tailor which compound and guidance we lead with.
Your Results
Your Research Pathway
Primary Recommendation
Retatrutide
Engineered to interact with GLP-1, GIP, and glucagon receptor systems.
Often Studied Alongside
Complementary research pathways
Based on what you've told us, most independent researchers start with a single vial before scaling up.
Add a Review